Когда воспаление становится диагностическим компасом: биомар

Когда воспаление становится диагностическим компасом: биомаркеры системных процессов как предикторы онкологического риска и персонализированной терапии Он

When Inflammation Becomes a Diagnostic Compass: Biomarkers of Systemic Processes as Predictors of Oncological Risk and Personalized Therapy When Inflammation Becomes a Diagnostic Compass: Biomarkers of Systemic Processes as Predictors of Oncological Risk and Personalized Therapy Twenty-first century oncology is undergoing a paradigmatic transformation—from organ-specific classification of malignant neoplasms to a molecular-taxonomic approach, where biomarkers reflecting not only tumor clone characteristics but also the metabolic, immunological, and inflammatory status of the host organism play a key role. The classical conception of oncogenesis as a sequence of genetic mutations in an isolated cell population is giving way to an understanding of malignant transformation as a complex multifactorial process, where the tumor microenvironment, systemic inflammation, metabolic disturbances, and comorbid conditions form a unique landscape that determines both the probability of neoplasia development and the response to therapeutic interventions. Epidemiological data from recent decades demonstrate a concerning trend: the growing prevalence of metabolic disorders, chronic inflammatory diseases, and obstructive conditions correlates with changes in oncological morbidity patterns. Overweight and obesity, according to analysis of data from reproductive women in Bangladesh, demonstrate sustained growth over a decade, which is paralleled in global trends. This metabolic epidemic is not merely a statistical phenomenon—it represents a biological foundation for the formation of a pro-inflammatory, pro-oxidant, and pro-oncogenic internal milieu. Visceral adipose tissue adipocytes function as endocrine organs, secreting adipokines, cytokines, and growth factors that modulate insulin signaling, mTOR pathway activity, chronic low-grade inflammation, and angiogenesis—all critical components of oncogenesis. The inflammatory component, traditionally considered in the context of rheumatological diseases, acquires a new dimension in the oncological context. Analysis of patients with axial spondyloarthritis reveals a high frequency of anemia associated with elevated inflammatory markers, illustrating the mechanism of chronic inflammation as a factor of systemic dysregulation. Anemia of chronic disease, mediated by hepcidin and interleukin-6, not only reduces quality of life but also creates a hypoxic microenvironment that promotes selection of aggressive tumor clones with high metastatic capacity. Therapy with anti-TNF-α agents demonstrates not only control of the inflammatory process but also correction of anemia, opening prospects for using inflammatory biomarkers as surrogate endpoints for monitoring not only rheumatological but also potentially oncological risks in patients with chronic systemic inflammation. Respiratory disturbances, especially obstructive sleep apnea, traditionally relegated to the competence of pulmonologists and sleep specialists, demonstrate unexpected connections with oncological processes through mechanisms of chronic intermittent hypoxia. A study of women with polycystic ovary syndrome complicated by obstructive sleep apnea reveals significant correlations between the severity of respiratory disturbances and adverse reproductive outcomes. Cyclic hypoxia-reoxygenation activates HIF-1α (hypoxia-inducible factor 1-alpha), induces VEGF (vascular endothelial growth factor) expression, stimulates angiogenesis, and suppresses apoptosis—molecular events identical to those observed in the tumor microenvironment. Moreover, chronic sleep fragmentation and hypoxemia are associated with oxidative stress, systemic inflammation, and immune dysfunction, creating a biological context favoring neoplasia initiation and progression. Nutritional status, long considered predominantly in the context of cachexia in oncological patients, deserves attention as a predictor and modifier of oncological risk at preclinical stages. A study of patients with frozen shoulder demonstrates the connection between nutritional profile, pain syndrome, and functionality, illustrating how metabolic imbalances affect tissue inflammation, regeneration, and pain sensitivity. Micronutrient deficiencies—selenium, zinc, vitamin D—compromise antioxidant defense, DNA repair, and immune surveillance, creating conditions for mutation accumulation and escape from immune control. Survival after oncological treatment is increasingly viewed not as an endpoint but as the beginning of a new life phase with unique medical and psychosocial needs. A review of unmet supportive care needs in head and neck cancer survivors reveals the multidimensionality of problems—from physical symptoms to psychological, social, and informational deficits. These needs not only affect quality of life; they may modify recurrence risks through mechanisms of chronic stress, immunosuppression, and behavioral factors. Integration of these diverse clinical observations into a unified conceptual framework requires reconceptualizing biomarkers not as isolated laboratory indicators but as reflections of complex biological networks linking metabolism, inflammation, immunity, and oncogenesis. Personalized oncology of the future will be based not only on the genomic profile of the tumor but also on an integrative assessment of the patient's systemic biological state, including metabolic, inflammatory, respiratory, and nutritional parameters. Metabolic Syndrome as Prologue to Oncogenesis: From Adipokines to Insulin Resistance Metabolic disturbances represent not merely risk factors but active participants in the oncogenic process, creating a biochemical environment favoring the initiation, promotion, and progression of malignant neoplasms. Analysis of data from reproductive women in Bangladesh for the period from 2007 to 2017-2018, presented by Anika and colleagues, demonstrates a dramatic increase in the prevalence of overweight and obesity. The prevalence of overweight inc…
All research articles Research digest Physician article feed